l reuteri atcc pta 6475 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
l reuteri atcc pta 6475
L Reuteri Atcc Pta 6475, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1015 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/l+reuteri+atcc/Lactobacillus+reuteri+(isolated+from+human+mother's+milk)%3A+L%2E+reuteri+MM4-1A/pm41829987-107-8-10
Average 96 stars, based on 1015 article reviews
L Reuteri Atcc Pta 6475, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1015 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/l+reuteri+atcc/Lactobacillus+reuteri+(isolated+from+human+mother's+milk)%3A+L%2E+reuteri+MM4-1A/pm41829987-107-8-10
Average 96 stars, based on 1015 article reviews
l reuteri atcc pta 6475 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Multifunctional Microneedle Patches Loaded With Engineered Nitric Oxide-Releasing Nanocarriers for Targeted and Synergistic Chronic Wound Therapy. Article Snippet: Chronic wounds impose significant physical and mental burdens on patients.. Nano-based formulations offer a promising strategy for chronic wound healing due to their non-invasive nature and enhanced biofilms penetration, but they often lack targeting capability or fail to achieve long-term and synergistic effects.. In this work, a multifunctional microneedle (MN) patch loaded with engineered nitric oxide (NO)-releasing nanocarriers are presented that encapsulate an antibacterial agent and are immobilized with Concanavalin A (Con A) and NO molecules for targeted and synergistic treatment of chronic wounds. Polymerase Chain Reaction:Article Title: Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Article Snippet: Article Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment Sequencing:Article Title: Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Article Snippet: Article Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment Software:Article Title: Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Article Snippet: Article Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment Bacteria:Article Title: Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome Article Snippet: .. C , D Fecal colonization of Article Title: Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome. Article Snippet: .. C, D Fecal colonization of Quantitative RT-PCR:Article Title: Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome Article Snippet: .. C , D Fecal colonization of Article Title: Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome. Article Snippet: .. C, D Fecal colonization of Cell Binding Assay:Article Title: Probiotic bacteria isolated from wolves and related compositions and methods Article Snippet: .. TABLE 6 AMP GEN KAN STR ERY CLI TET CHL MIC (mm) (10 μg) (10 μg) (30 μg) (10 μg) (15 μg) (2 μg) (30 μg) (30 μg) E. coli ATCC 25922 20 22 23 18 0 0 25 24 P. aeruginosa ATCC 27853 0 17 0 7 0 0 14 0 S. aureus ATCC 25923 32 22 22 14 26 24 28 23 E. faecium WF-3 22 14 13 7 17 24 0 25 L. casei K9-1 45 29 18 21 50 22 45 36 L. fermentum K9-2 35 24 18 17 36 36 28 31 L. fermentum ATCC 14931 44 21 9 10 40 42 26 35 In Vitro:Article Title: Probiotic bacteria isolated from wolves and related compositions and methods Article Snippet: .. TABLE 6 AMP GEN KAN STR ERY CLI TET CHL MIC (mm) (10 μg) (10 μg) (30 μg) (10 μg) (15 μg) (2 μg) (30 μg) (30 μg) E. coli ATCC 25922 20 22 23 18 0 0 25 24 P. aeruginosa ATCC 27853 0 17 0 7 0 0 14 0 S. aureus ATCC 25923 32 22 22 14 26 24 28 23 E. faecium WF-3 22 14 13 7 17 24 0 25 L. casei K9-1 45 29 18 21 50 22 45 36 L. fermentum K9-2 35 24 18 17 36 36 28 31 L. fermentum ATCC 14931 44 21 9 10 40 42 26 35 |